ERBB2 and triple-negative breast carcinoma: Triple-negative breast cancer (TNBC) that lacks estrogen and progesterone receptors as well as human epidermal growth factor receptor 2 (HER2) is the most aggressive subtype, with high metastatic and recurrence rates.